Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline-Reference-Cited by-同舟云学术

Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline

Published:2008-10-01 Issue:10 Volume:93 Page:3777-3784
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Colao Annamaria¹,Galderisi Maurizio²,Di Sarno Antonella¹,Pardo Moira²,Gaccione Maria¹,D'Andrea Marianna¹,Guerra Ermelinda¹,Pivonello Rosario¹,Lerro Giuseppe²,Lombardi Gaetano¹

Affiliation:

1. Department of Molecular and Clinical Endocrinology and Oncology (A.C., A.D.S., M.Gac., M.D., E.G., R.P., G.Lo.) Section of Cardioangiology, Federico II University of Naples, 80131 Naples, Italy

2. Section of Endocrinology, and Department of Clinical and Experimental Medicine (M.Gal., M.P., G.Le.) Section of Cardioangiology, Federico II University of Naples, 80131 Naples, Italy

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/93/10/3777/9053421/jcem3777.pdf

Reference34 articles.

1. Advances in the treatment of prolactinomas.;Gillam;Endocr Rev,2006

2. Diagnosis and initial management of Parkinson’s disease.;Nutt;N Engl J Med,2005

3. Restless legs syndrome.;Earley;N Engl J Med,2003

4. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours;Colao;Eur J Endocrinol,2007

5. The US Food and Drug Administration’s registry of patients with pergolide-associated valve heart disease.;Flowers;Mayo Clin Proc,2003

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of the new FIGO classification of ovulatory disorders;Human Reproduction Update;2024-02-27

2. Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment;Frontiers in Endocrinology;2024-02-02

3. Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming;Frontiers in Immunology;2023-07-05

4. Approach to the Patient With Prolactinoma;The Journal of Clinical Endocrinology & Metabolism;2023-03-28

5. Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies;British Journal of Clinical Pharmacology;2023-01-30